These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3772911

  • 21. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime.
    Knopp RH.
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1630-43. PubMed ID: 3287934
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K.
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [Abstract] [Full Text] [Related]

  • 25. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB.
    Arch Intern Med; 1997 Jun 09; 157(11):1186-92. PubMed ID: 9183229
    [Abstract] [Full Text] [Related]

  • 26. OC practice guidelines: minimizing side effects.
    Darney PD.
    Int J Fertil Womens Med; 1997 Jun 09; Suppl 1():158-69. PubMed ID: 9168375
    [Abstract] [Full Text] [Related]

  • 27. Oral contraceptives and cardiovascular disease (second of two parts).
    Stadel BV.
    N Engl J Med; 1981 Sep 17; 305(12):672-7. PubMed ID: 7022211
    [No Abstract] [Full Text] [Related]

  • 28. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F.
    Contracept Fertil Sex (Paris); 1984 Sep 17; 12(9):1076-7. PubMed ID: 12266510
    [Abstract] [Full Text] [Related]

  • 29. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr 17; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 30. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.
    Bradley DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S.
    N Engl J Med; 1978 Jul 06; 299(1):17-20. PubMed ID: 207983
    [Abstract] [Full Text] [Related]

  • 31. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb 06; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 32. Effects of sex steroid hormones on lipoprotein levels in pre- and post menopausal women.
    Knopp RH.
    Can J Cardiol; 1990 May 06; 6 Suppl B():31B-35B. PubMed ID: 2188717
    [Abstract] [Full Text] [Related]

  • 33. Letter: Myocardial infarction and estrogen therapy in premenopausal women.
    Rosenberg L, Armstrong B, Jick H.
    N Engl J Med; 1976 Jun 03; 294(23):1290-1. PubMed ID: 1264157
    [Abstract] [Full Text] [Related]

  • 34. The pharmacologic and metabolic effects of oral contraceptives.
    Mishell DR.
    Int J Fertil; 1989 Jun 03; 34 Suppl():21-6. PubMed ID: 2576252
    [Abstract] [Full Text] [Related]

  • 35. [Hormone replacement therapy and cardiovascular risk].
    Maffei S, De Caterina R.
    G Ital Cardiol; 1996 Aug 03; 26(8):899-940. PubMed ID: 9005173
    [Abstract] [Full Text] [Related]

  • 36. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 03; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 37. [Myocardial infarct in young women and steroid contraception].
    Presl.
    Cesk Gynekol; 1976 Apr 03; 41(2):156. PubMed ID: 1268974
    [Abstract] [Full Text] [Related]

  • 38. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML.
    J Reprod Med; 1999 Feb 03; 44(2 Suppl):221-6. PubMed ID: 11392036
    [Abstract] [Full Text] [Related]

  • 39. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug 03; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 40. [Estrogens, progestins and blood lipids].
    Tikkanen MJ.
    Duodecim; 1984 Aug 03; 100(22):1500-3. PubMed ID: 6518995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.